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Abstract 
 
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease that limits airflow and 
breathing in people worldwide. COPD is considered one of the leading causes of death in Americans and 
the primary factor contributing to diagnosis is smoking (CDC, 2019). Through the progression of this 
chronic disease, those suffering experience great impacts to their everyday lives. A registered dietitian 
nutritionist’s (RDNs) job is to ensure adequate care through thorough assessment, diagnosis, treatment 
and evaluation, otherwise known as the Nutrition Care Process (ADIME-NCP). My uncle has been 
diagnosed with COPD and I have had the opportunity to witness this progression through the last year. It 
has given me great understanding into the struggles and hardships that come with this disease.  
 
DEFINITION & PATHOPHYSIOLOGY 
 Chronic Obstructive Pulmonary Disease (COPD) as mentioned before is a progressive disease 
that severely limits the airways and breathing. It can include inflammation of the lining of the bronchial 
tubes otherwise known as bronchitis or destruct the alveoli in the lungs called emphysema, often times 
patients will experience both disorders. COPD is classified into four groups according to the Global 
Initiative for Chronic Obstructive Lung Disease also known as GOLD. These classifications include the 
level, description and spirometry results to assess the severity of the patient’s airflow limitations 
(Nelms, Sucher, Lacey, 2016). 
  GOLD 1- Mild: FEV1 >80% predicted 
  GOLD 2- Moderate: 50% < FEV1 < 80% predicted 
  GOLD 3- Severe: 30% < FEV1 <50% predicted  
  GOLD 4- Very Severe: FEV1 < 30% predicted  
  *FEV1- Forced Expiratory Volume in 1 second* 
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COPD is currently incurable and is most often times caused by long-term exposure to irritating 
gases such as smoking (CDC, 2019). Chronic bronchitis, asthma and emphysema are the primary 
conditions associated with COPD. With repeated exposure to irritants, pollutants and smoking results in 
inflammatory responses in the lungs or bronchial tubes. In bronchitis this inflammatory response 
includes decreased cilia function, increased phagocytosis and decreased immunoglobulin A (IgA). The 
inflammation causes hyperplasia of mucus-secreting cells resulting in edema of the bronchioles. Due to 
thickened mucus in the bronchioles bacterial growth is prominent and often times respiratory infections 
occur. Bronchitis is characterized by decreased airflow rates, dyspnea, hypoxemia and hypercapnia 
(Nelms, et al., 2016). 
Emphysema usually develops later as a complication of bronchitis and can cause actual damage 
to the lung tissue. Damage to the lung results in loss of surface area and decreases the elasticity of the 
lung resulting in breathlessness. Decreased expiratory volume or FEV is a result of emphysema, 
expiration is impaired because air is often times trapped in the lungs. Due to decreased ability to expire, 
dyspnea and orthopnea occur causing respiratory acidosis or excess CO2 in the lungs making them too 
acidic. Extreme fatigue occurs in patients because of the increased use of accessory muscle to expire 
oxygen (Nelms, et al., 2016). 
 
ETIOLOGY  
 One of the most principle classifications for COPD is chronic bronchitis and can be diagnosed 
with coughing and shortness of breath that last about 3 months or more each year for two or more 
years in a row. Bronchitis can be found in all ages but is most commonly prevalent in those over the age 
of 45, with females being twice as likely to develop bronchitis. Emphysema usually develops over years 
as a result of chronic bronchitis, the two chronic illnesses together are collectively known as COPD. 
Common signs and symptoms to notice in COPD are shortness of breath, wheezing, chest tightness, 
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excess mucus in lungs, chronic cough, blueness of lips, respiratory infections, fatigue, unintentional 
weight loss and edema this can often be observed through a Nutrition Focused Physical Exam (NFPE). 
The main cause of COPD is chronic smoking and tobacco use but can be related to those who have long-
term exposure to heavy fumes such as those in third world countries. Some other potential causes 
include genetic susceptibility, secondhand smoke, air pollution and workplace exposure to dust, smoke 
and fumes. COPD can also be caused by a deficiency in protein called AAt or alpha-1-antitrypsin but is 
only found in 1% of those who are diagnosed (Nelms, et al., 2016). 
 
EPIDEMIOLOGY 
 Lower respiratory lung diseases especially COPD is the third leading cause of death in 
Americans. Death rates due to COPD have declined in America for men but have not significaly changed 
for women and highest rates of COPD are found in southern states. Deaths from COPD can still occur in 
individuals who have successfully quit smoking due to the associated inflammatory stress that continues 
to damage the lungs. Normal lung function declines with age but those who smoke or are exposed to air 
pollutants develop symptoms more rapidly and twice the rate. I have experienced the effects of lung 
disease and the tolls it takes on the body. My uncle has successfully quit smoking, but it has done little 
to aid in his symptoms of COPD. He struggles to do the normal tasks of those who are able bodied from 
walking up the stairs to getting himself to shower depending on his oxygen. He has had to adjust to his 
limitations but coping mentally with the terms of his condition has been the hardest. Some days are 
better than others, but he has learned to take it one step at a time (COPD Foundation, 2019), (Mayo 
Clinic, 2017). 
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COMPLICATIONS & PREVENTION  
 COPD can cause many side effects or complications of daily living. I have witnessed this in my 
uncle, but every individual is different and experiences the disease differently. The most common 
complications include activity limitations, dependency on oxygen devices, increased confusion or 
memory loss, respiratory infections, comorbidities of heart, lung and artery diseases as well as 
depression. As for prevention, COPD is unique in that there is a direct cause to the disease, preventing 
the use of tobacco or quitting decreases the chances of COPD ten-fold (Nelms, et al., 2016). 
 
NUTRITION ASSESSMENT 
 The nutrition assessment is used by the RDN to formulate a complete overview of the 
nutritional health of the patient. Every patient is a unique individual and requires treatment that is 
catered to their specific nutritional needs. Careful consideration of each assessment piece is crucial to 
providing accurate and adequate care for the patient. The nutrition assessment provides data from 
client histories, food and nutrition-related history,anthropometric and biochemical data. All data can be 
both subjective meaning information comes from the patient, family or caregivers as well as objective in 
which information comes from verifiable sources such as medical records.  
Client History 
 Nutritional status can be impacted by factors relating to socioeconomic status, social support 
systems, family relations and lifestyle factors. Information gathered from the nutrition assessment 
especially the client’s history will impact the course of action for nutrition education and intervention. 
For patients with COPD their client history assessment should include any current and past medical 
diagnoses including surgeries, psychological status, education (literacy and primary language), current 
stage of diagnosis and any other concerning medical histories.   
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 My uncle has lived a tough life and has not treated his body with the care that it deserves. He 
struggled to support himself and often found himself homeless or living in shelters, he entered a life 
where tobacco and alcohol use were the only thing he depended on. His socioeconomic status varied 
throughout the years, mostly due to job hopping, he currently is living with us and is the most stable 
he’s been in in years. Other than us (his immediate family) and hospice my uncle does not have any 
other social support, back where he was living, he only relied on himself and food that we would send 
him to eat. This was done through a community-based project like meals on wheels that would bring 
him meals to where ever he was living. He was able to utilize some government funded resources such 
as food stamps, and low-income housing but it was always a struggle trying to get him to stick with it 
and fully utilize them. His current diagnoses include stage 4 COPD, lung disease, osteoporosis (history of 
many severe broken bones including the back and femur), depression, confusion and hallucinations, 
heart disease and histories of strokes. He’s currently on Hospice and has been for the last eight months 
and has entered end of life care (Nelms, Sucher, Lacey, 2016). 
Food and Nutrition Related History 
 Many factors of COPD impact patient’s nutritional intake so designing a nutrition care plan is 
crucial to ensure adequate nutrition and minimize symptoms of the disease. Possible factors that may 
inhibit adequate nutritional intake include anorexia, early satiety, dyspnea, bloating and fatigue. Some 
important areas that the RDN should considered is whether the patients taste perception has been 
altered, appetite loss due to depression, unintentional weight loss, cachexia and fatigue that comes with 
difficulty breathing while eating. My uncle experiences a lot of these complications, when he first moved 
in with my family, he gained 35 pounds and was on a road to better health. He then experienced a 
transient ischemic attack (TIA) and from there his health severely declined his weight being majorly 
affected.  
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  Antioxidant intake, increased respiratory health and increasing oral health play key roles in 
protecting against COPD and progression of COPD. It has been shown for some COPD patients that 
consuming fewer carbohydrates and more essential fatty acids and protein may help them breathe 
better. According to the American Lung Association some nutritional recommendations that they 
offered included limiting simple carbohydrates, eating 20-30 grams of fiber daily specifically from fruits, 
whole grains and vegetables, choosing mono- and poly saturated fats, limiting sodium intake to 
decrease edema and increasing fluid to help constipation that may be due to medications or increasing 
fiber intake (American Lung Association, 2018). From here assessing their ability to feed themselves, 
cook and prepare foods and overall food security should be noted for any potential limiting factors to 
adequate oral intake.  
My uncles past included years of food insecurity and once he finally was in stable environment 
where food was at his access at all times, he was able to put on a healthy amount of weight, since then 
it has declined. Medication usage must be evaluated to determine if any are impacting appetite, side 
affects and oral intake. Careful attention to glucocorticosteroids decrease intestinal absorption of key 
nutrients that can lead to osteoporosis. Many of these patients are recommended to also receive 
bisphosphonates to prevent the onset of osteoporosis. My uncle takes an abundance of medications 
that really affect his overall appetite and he often struggles with constipation as a symptom of 
medication usage.  
 Utilizing a 24-hour recall, diet history and food frequency will help give the RDN an idea of what 
a typical diet may look like for the patient. Gaining this understanding can help later on when 
determining a diagnosis and intervention plan that ensures adequate intake orally. The diet history can 
establish usual intake, food preferences, alcohol intake, any type of supplementation and food allergies. 
This is important as recommendations can be made to adjust oral intake to small, frequent meals with 
modified textures if needed. As mentioned before all patients diagnosed with COPD are all 
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individualized and at different stages in their progression of COPD, this meaning that oral intake may be 
different with each patient. It is critical to understand where they are in their progression, it can be 
helpful for the RDN to utilize these assessment tools (Nelms, Sucher, Lacey, 2016). 
Anthropometric Data 
 Anthropometric data is often obtained through the use of medical records and provides the 
patients height, age, current weight, weight history including usual body weight, and BMI. Weight loss 
and low BMI are commonly associated with mortality in patients with COPD. Unintentional weight loss is 
also a common side effect of emphysema and is related to the increased resting energy expenditure 
needed for altered breathing. Depletion of lean body mass is normal with the progression and can be 
assessed through BMI and history of body weight. These data markers come into play later when 
determining goals for intervention and monitoring the progress through observation of anthropometric 
data (Nelms, Sucher, Lacey, 2016).  As mentioned, my uncles’ weight initially increased by about 35 
pounds with his usual body weight for that time being around 130-140 pounds, and his health significaly 
improved. After his most recent TIA his weight, appetite, ability to consume foods and overall health 
declined and he now currently weighs around 90 pounds. He is very frail and relies on a walker or 
wheeler chair for mobilization, I know he presents with major signs of malnutrition especially muscle 
wasting, fat loss, unintentional weight loss and edema.  
Biochemical Data 
 Biochemical data indicates nutritional markers for laboratory findings including acid-base 
balances, electrolyte and renal profiles, gastrointestinal profiles, glucose and endocrine levels, 
inflammatory response, metabolic rate, mineral-vitamin intake, deficiencies, total macronutrient intake 
and urine profiles. These markers can be assessed and indicated through evaluation of organ function, 
blood, urine, feces and tissue samples. Every disease state and diagnosis will present with different 
biochemical data findings and associations, understanding what these lab values mean is important to 
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understanding the overall state of the patient. My uncle since his admission to Hospice often gets his 
blood drawn, urine and feces output checked and observance of his skin to assess where he is at and 
what kind of end of life treatment is to be given. Standard laboratory indicators used for patients with 
COPD range from different medical lab tests, procedures and assessments. Visceral protein assessment 
is standard to interpret carefully during periods of systemic inflammation, hematological tests, 
electrolytes, pH, glucose and arterial blood gases are often checked. Often times inflammatory markers 
are checked such as C-reactive protein (CRP: normal range: below 3.0mg/L), fibrinogen (normal range: 
160-450mg/dL) and erythrocyte sedimentation (ESR: normal range: males-1-13mm/hr., females-1-
20mm/hr.), these are important to monitor during bouts of inflammation. Many vitamins and minerals 
can be monitored as well to help indicate nutritional status these include vitamin D (normal range-12-
20ng/mL), vitamin K (normal range: 0.2-3.2ng/mL), vitamin A (RDA: men-900ug/RAE., women-
700ug/RAE), vitamin E (RDA: 15 mg alpha-tocopherol) and Zinc (RDA: men-11mg, women-8mg) 
(Meditec, 2019), (Nelms, Sucher, Lacey, 2016). 
 Assessment of anemia is important in the evaluation of dyspnea, along with pulmonary function 
tests (PFTs) especially spirometry to assess the severity of airflow limitations, response to certain 
medications and progression of the disease. Other tests than can be included in assessing COPD patients 
include: lower limit of normal FEV1/FVC, forced expiratory volume in six seconds, peak expiratory flow, 
lung volume, diffusing capacity, pulse oximetry and arterial blood gases. Below is the chart for forced 
expiratory volumes.  
GOLD 1- Mild: FEV1 >80% predicted 
  GOLD 2- Moderate: 50% < FEV1 < 80% predicted 
  GOLD 3- Severe: 30% < FEV1 <50% predicted  
  GOLD 4- Very Severe: FEV1 < 30% predicted  
  *FEV1- Forced Expiratory Volume in 1 second* 
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 All common medications prescribed for patients with COPD can have side effects that affect the 
patient’s ability to stay nutritionally adequate (Nelms, Sucher, Lacey, 2016). 
 Corticosteroids: Prednisone and Solu-Mefrol- used to reduce inflammation in the bronchial 
tubes, can be used in the form of an inhaler or taken orally. Side effects depend on the dosage, 
length of use, and form. Side effects for inhalers include sore mouth, hoarse voice, infection in 
the through and cough. Orally include altered fluid/electrolyte balance, hypertension, mood 
swings, increased appetite, weight gain, hyperglycemia, osteoporosis, hyperlipidemia, poor 
wound healing.  
 Bronchodilators: B2-agonists, Anticholinergics, Theophyllines- open or relax the bronchial tubes 
and relieve shortness of breath, this can also be taken orally or through an inhaler. Side effects 
include fast heartbeat, shakiness, camping of the hands, legs or feet, dry mouth, severe nausea 
and vomiting.  
 Leukotriene Inhibitors: Zafirlukast, Aileuton, Montelukasts- mediates the inflammation 
associated with COPD. Side effects include headache, nausea, diarrhea, infection and caution 
with intake of grapefruit.  
 Mucolytics: Acetylcysteine- helps make the mucus in the lungs thinner and less sticky. Side 
effects include nausea, vomiting, runny nose, drowsiness and clammy skin. 
 Antibiotics: are used to treat bouts of respiratory infections, some side effects include nausea, 
vomiting and diarrhea.  
I am not aware of all the medications that my uncle is taking, his Hospice nurses and my parents 
take care of all the administration of them. I do see them often times leaving syringes of morphine 
for him when he feels he needs to take them for his pain and every night my mom crushes up his 
meds and places them in his favorite homemade applesauce, he struggles to swallow them 
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otherwise. He struggles with constipation and nausea, so I know he is prescribed to take stool 
softeners every day and nausea medication to help him with his appetite.  
 
NUTRITION DIAGNOSIS 
 The RDNs role in the nutrition diagnosis is to identify and label existing nutrition problems that 
the RDN is properly able to treat through intervention and treatment. Standard terminology exists for 
this section of the nutrition care process and three prominent domains exist for possible diagnoses for 
patients. These include the intake domain relating to the energy needs being consumed or not 
consumed, clinical relating to medical or physical conditions and behavioral-environmental domain 
where knowledge attitudes, beliefs, environment and food accessibility play a role. Shortness of breath, 
chronic coughing and chest discomfort often times causes patients with COPD difficulty eating enough 
and maintaining their weight. Major diagnoses often times include statements relating to finding ways 
to increase energy intake and avoidance of unintentional weight loss. In COPD hypermetabolism 
increases a patient daily REE which may be a side effect increased thoracic muscle use, inflammation 
from elevation of C-reactive protein, fibrinogen and leukocytes as well as possibly thermogenic effects 
of medication use. Optimal energy balance is crucial to preserve body weight, lean body mass and 
overall daily living of COPD patients. According to the AND Evidenced Analysis Library it is important that 
each individual receives sufficient calories and protein and it has been recommended that energy intake 
of 125-156% (average of 140%) above basal energy expenditure and protein intake of 1.2-1.7 g/kg/body 
weight are adequate to avoid deficiencies. If patient is malnourished already, it could be important to 
increase needs even more for repletion of adequate nutrient stores. Using 25-35 kcal/kg of body weight 
is appropriate with approximately 20-25% of calories coming from protein. It was once thought that 
carbohydrate intake could impact respiratory function due to increased CO2 production and complicate 
ventilation, but it is now thought that primary concern is overfeeding of patients.   
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)                                                                                       
12 
 
 Many nutrition diagnoses can be appropriate for a patient with COPD and can range in all three 
different domains. Some common diagnoses include malnutrition, inadequate energy or oral intake, 
inadequate fluid intake, inadequate protein intake, inadequate vitamin-mineral intake, increased 
nutrient needs, food-medication interactions, swallowing difficulty, unintended weight loss, impaired 
ability to prepare food/meals, self-feeding difficulty, poor nutrition quality of life (Nelms, Sucher, Lacey, 
2016). 
Possible PES Statements 
 Inadequate energy intake related to unintentional weight loss as evidenced by <50% of intake of 
estimated energy requirements, weight loss of 7.5% in 3 months and increased REE 
requirements due to hypermetabolism  
 Chronic disease or condition related malnutrition related to loss of appetite as evidenced by 
unintentional weight loss of 7.5% in 3 months, early satiety, altered taste perceptions, muscle 
and fat wasting and edema 
 Inadequate protein intake related to decreased appetite as evidenced by decreased immune 
function, chronic infections, decreased wound healing, <20% of daily intake of protein and 
decreased lean body mass/muscle  
 Food-Medication interaction related to use of Corticosteroids (Prednisone and Solu-Mefrol) as 
evidenced by mouth sores, increased appetite, unintentional weight gain, hyperglycemia and 
hyperlipidemia 
 Swallowing difficulty related to COPD as evidenced by dyspnea, chronic mouth breathing, 
chronic mucous production, chronic coughing, mouth sores, dry mouth and in some cases, 
dysphasia often from TIAs or Strokes 
In my opinion I believe my uncle would be diagnosed with malnutrition, difficulty swallowing, and 
inadequate energy intake including symptoms of unintentional weight loss, loss of appetite, TIA side 
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effects, edema, muscle wasting, dysphasia, decreased wound healing, chronic mucous production, 
chronic coughing and decreased immune function.  
 
POSSIBLE INTERVENTIONS & TREAMENT 
 There are four categories of nutrition intervention they include food and/or nutrient delivery, 
coordination of care, nutrition education and nutrition counseling. For patients with COPD I would 
recommend choosing treatment pertaining to the food and/or nutrient delivery and coordination of 
care and nutrition education. With that, depending on what stage of COPD they are in I would utilize 
nutrition education and counseling if necessary. If a patient is in the beginning stages these may be 
important to helping the patient slow the progression of their disease but if a patient is further along in 
the progression of COPD nutrition education and counseling are not going to be as effective. Some 
possible interventions and treatments include: 
 Increase intake of nutrient dense foods consuming foods high in protein and calories. 
 Decrease sodium intake to decrease changes of edema and hypertension  
 Dietary education regarding nutrient dense foods, and important of high calorie/protein 
foods for overall health 
 Educating patients on the importance of resting before meals to avoid fatigue and tiredness 
while eating 
 Eating smaller meals, more frequent meals rather than three big meals throughout the day 
will help to alleviate the feeling of fullness and fatigue 
 Nutritional supplementation to provide additional calories, protein and mineral/vitamin 
intake, focuses should be on vitamin D, calcium and antioxidants  
 Increasing physical activity or rehabilitation for patients to increase lean body mass and lung 
strength (performing ADL exercise to increase quality of life for patient) 
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 Avoiding beverages that are filling but do not calories or protein such as coffee, tea and diet 
soft drinks 
 If dysphagia is present modification of textures can be introduced for easier swallowing while 
eating 
 For constipation related to medication use, increasing fiber intake may be useful 
 If able to prepare own food, education on easy to prepare foods for patients or adapting a 
system to help patient prepare food for themselves  
 Coordination of care to Speech language pathologist (SLP) for any swallowing or dysphagia 
difficulty  
 Coordination of care to social work for any potential resources for the client  
 Nutrition Counseling using MI, transtheoretical stages of change model and health belief 
models to help gear patient towards a better attitude towards health, nutrition and 
understanding of slowing the progression of the diagnosis  
I have been able to witness my uncle during meal times and since his TIA he has struggled with 
major fatigue, appetite loss, and dysphagia while eating. He is able to do some cooking but not a lot, my 
family and his nurses often times will make him food to eat when he is feeling up to it. We keep a lot of 
easy to prepare food on hand for him and often keep foods such as whole milk, butter and high calorie 
options to add to his meals to increase his calorie intake. He enjoys hot chocolate, ice cream, 
homemade applesauce, soups and (of all things) fish! We are aware of his dysphagia and difficulty 
swallowing but he has expressed that he does not want a swallow study done or modified textured 
foods. To combat we often cut up his foods to smaller bite sized pieces or serve foods that can be easily 
mashed and chewed for him. He usually consumes about 25% or less of his meals but sometimes he will 
have bouts of increased appetite in which we try to have him eat more. I think overall, he is aware of the 
importance of eating and getting in proper nutrition, but he struggles do so which is expected at his 
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stage of COPD. He eats when he can and often eats small frequent meals throughout the day to combat 
his tiredness and fatigue with meal times.  
 
MONITORING & EVALUATION 
 In relation to the patient’s fatigue, altered taste perception, oral intake, increased caloric intake, 
mineral intake (sodium primarily), swallowing difficulty, medication induced constipation, nausea and 
overall malnutrition it is key for the RND to provide proper monitoring and evaluation to assess the 
patient’s progression of COPD. Toward the latter stages of COPD, it may be decided the enteral nutrition 
be induced if ethical to provide adequate nutrition. Monitoring of energy intake throughout can help to 
assess if this is necessary or to determine future course of nutrition intervention. Some ways to monitor 
the patient’s nutritional status is through weight, (if in a care home) food intakes (0-100% intakes), 
observance of malnutrition status through NFPEs and appetite to name a few (Nelms, Sucher, Lacey, 
2016). 
 Right now, hospice does most of the evaluation of my uncle, assessing his nutritional status and 
progress with his COPD. Since he is on hospice, RDNs are not used at this stage of life and therefore 
nursing, doctors and my family are in charge of keeping track of his nutritional status. It can be difficult 
at times, because he is not always truthful about his nutritional intake when we are not there to observe 
him at meal times.  
 Through the nutrition care process, I have been able to outline a typical process in which a 
patient diagnosed with COPD would experience with an RND. With that being said, each patient is 
individualized and will most likely all be at different stages in their progression requiring different plans 
of nutritional treatment to best care for them. Keeping this in mind will be crucial to assessing what is 
going to be best for the particular patient at hand. I think COPD can be difficult because there is not cure 
and will ultimately progress to the furthest stage which can be hard not only on the family but the care 
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providers in their treatment. Having an open mind and being open to trying all things to best treat the 
patient is the best route to go with patients who are experiencing chronic disease.  
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